Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention
Recruiting · NCT05933122 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Limoges
View the official record on ClinicalTrials.gov →Interventions studied
sexologist consultstandart of care
What this trial is about
RectSexQoL is a study aiming at determining the prevalence of female sexual dysfunction after rectal cancer surgery. It has the goal as well to analyse the impact of an intervention given by a sexologist to such patients.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Women
- Diagnosis of stage I-III rectal adenocarcinoma or rectosigmoid junction with anastomosis less than 15 cm from the anal margin
- Surgical management, preceded or not by Radio-chemotherapy, with restoration of continuity
- Age : over 18
- Proficiency in French or English
Exclusion criteria
- Current pregnancy
- Significant cognitive/psychiatric disorders
- Guardianship
Where it is running
6 locations listed.
- Brive Hospital - Brive-la-Gaillarde, France
- Les cedres Clinical - Brive-la-Gaillarde, France
- Gueret Hospital - Guéret, France
- Chenieux clinical - Limoges, France
- Limoges University Hospital - Limoges, France
- Saint Junien Hospital - Saint-Junien, France